IP Verse

Pinsent Masons patent opposition analysis

The comprehensive analysis of Pinsent Masons opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Pinsent Masons

Stay updated with the latest patent oppositions filed by Pinsent Masons

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3411021
New Use Of A Combination Of Sacubitril And ValsartanNOVARTIS AGFeb 10, 2026LANYON OPPOSITIONS
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AGJan 30, 2026LANYON OPPOSITIONS
EP4234033
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF. HOFFMANN-LA ROCHE AGOct 28, 2025LANYON OPPOSITIONS
EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS AGJul 23, 2025LANYON OPPOSITIONS
EP3853305
High-Purity Peg Lipids And Uses ThereofMODERNAJul 2, 2025LANYON OPPOSITIONS
EP4241849
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF. HOFFMANN-LA ROCHE AGJun 17, 2025LANYON OPPOSITIONS
EP3589661
Adjuvant Treatment Of Her2-Positive Breast CancerGENENTECH, INC.Jul 31, 2024LANYON OPPOSITIONS
EP3703818
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJul 30, 2024LANYON OPPOSITIONS
EP3626270
New UseNOVARTIS AGJul 11, 2024LANYON OPPOSITIONS
EP3294283
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AGDec 7, 2023STRAWMAN

Top clients of Pinsent Masons

Top companies who are the clients of Pinsent Masons

CompanyTotal
LANYON OPPOSITIONS9
STRAWMAN2